Arrowhead Research | ARWR - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 1.05M 2026-06
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.89B 12.09M 2026-09
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
TG Therapeutics USD 153.08M 2.23M 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Xencor USD 74.33M 265K 2026-06